REGENERX BIOPHARMACEUTICALS, INC. Operating Lease, Liability, Current
REGENERX BIOPHARMACEUTICALS, INC. had Operating Lease, Liability, Current of $46.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2023-05-15
- 2023-03-31: Operating Lease, Liability, Current $46.00K.
- 2022-12-31: Operating Lease, Liability, Current $43.38K.
- 2022-09-30: Operating Lease, Liability, Current $33.21K.
- 2022-06-30: Operating Lease, Liability, Current $4.17K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2023-03-31 | $46.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $43.38K 10-Q · filed 2023-05-15 |
| 2022-09-30 | $33.21K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $4.17K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $16.28K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $27.81K 10-K · filed 2023-04-11 |
| 2021-09-30 | $38.78K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $45.04K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $42.86K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $40.79K 10-K · filed 2022-03-30 |
| 2020-09-30 | $38.82K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $36.84K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $15.89K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $27.01K 10-K · filed 2021-03-02 |
| 2019-09-30 | $37.37K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $47.23K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $48.46K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-20 |